BlackRock Inc. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$243,005,943
-11.5%
25,234,262
-2.2%
0.01%
-12.5%
Q2 2023$274,560,679
+3.1%
25,804,575
+1.9%
0.01%0.0%
Q1 2023$266,344,413
-16.6%
25,317,910
-1.8%
0.01%
-20.0%
Q4 2022$319,332,192
+23.4%
25,773,381
+3.2%
0.01%
+11.1%
Q3 2022$258,688,000
-16.6%
24,970,098
-7.1%
0.01%
-10.0%
Q2 2022$310,044,000
+69.5%
26,890,220
+85.0%
0.01%
+100.0%
Q1 2022$182,873,000
+9.2%
14,536,759
+1.2%
0.01%
+25.0%
Q4 2021$167,541,000
+2.9%
14,368,890
+15.2%
0.00%
-20.0%
Q3 2021$162,883,000
+9.6%
12,471,775
+8.0%
0.01%
+25.0%
Q2 2021$148,662,000
-0.4%
11,550,907
-13.5%
0.00%0.0%
Q1 2021$149,239,000
+0.4%
13,348,564
+2.3%
0.00%
-20.0%
Q4 2020$148,580,000
+17.2%
13,044,650
-7.4%
0.01%0.0%
Q3 2020$126,733,000
-15.1%
14,089,184
-2.6%
0.01%
-16.7%
Q2 2020$149,313,000
+10.9%
14,468,180
+8.5%
0.01%
-14.3%
Q1 2020$134,601,000
-25.3%
13,340,266
-1.5%
0.01%0.0%
Q4 2019$180,237,000
+56.0%
13,541,545
+0.6%
0.01%
+40.0%
Q3 2019$115,516,000
-17.1%
13,455,583
+5.7%
0.01%
-16.7%
Q2 2019$139,270,000
-14.4%
12,730,319
+5.8%
0.01%
-14.3%
Q1 2019$162,768,000
+27.6%
12,030,163
-2.3%
0.01%
+16.7%
Q4 2018$127,610,000
-43.3%
12,317,565
+1.0%
0.01%
-40.0%
Q3 2018$225,188,000
-0.2%
12,198,644
+3.3%
0.01%0.0%
Q2 2018$225,728,000
+30.2%
11,805,955
+5.0%
0.01%
+25.0%
Q1 2018$173,408,000
-1.1%
11,238,427
-4.0%
0.01%0.0%
Q4 2017$175,414,000
-6.3%
11,702,048
-1.4%
0.01%
-11.1%
Q3 2017$187,237,000
-14.2%
11,872,904
+2.7%
0.01%
-25.0%
Q2 2017$218,310,000
+12.6%
11,562,975
+1.7%
0.01%
+9.1%
Q1 2017$193,944,000
+43385.2%
11,368,314
+38835.2%
0.01%
+1000.0%
Q4 2016$446,000
+51.7%
29,198
+57.6%
0.00%
Q3 2016$294,000
+57.2%
18,525
+29.5%
0.00%
Q2 2016$187,000
+92.8%
14,309
+60.8%
0.00%
Q1 2016$97,000
+34.7%
8,898
+42.4%
0.00%
Q4 2015$72,000
+100.0%
6,248
+81.6%
0.00%
Q3 2015$36,000
-12.2%
3,4400.0%0.00%
Q2 2015$41,000
-29.3%
3,440
-5.6%
0.00%
Q1 2015$58,000
+3.6%
3,6430.0%0.00%
Q4 2014$56,000
+19.1%
3,6430.0%0.00%
Q3 2014$47,000
-16.1%
3,6430.0%0.00%
Q2 2014$56,000
+30.2%
3,643
+2.7%
0.00%
Q1 2014$43,000
-87.3%
3,548
-87.9%
0.00%
-100.0%
Q4 2013$339,000
-2.0%
29,2120.0%0.00%0.0%
Q3 2013$346,000
+19.3%
29,2120.0%0.00%0.0%
Q2 2013$290,00029,2120.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders